CTOs on the Move

VytronUS

www.vytronus.com

 
VytronUS, Inc. was formed in 2006 to harness the imaging and therapeutic capabilities of ultrasound energy to treat cardiac arrhythmias, starting with atrial fibrillation. We recognize that today`s marketed technologies have limitations. Only a new energy source, such as collimated ultrasound, can shift the treatment paradigm to more predictable outcomes. We strive to make a complicated procedure simple. Ease of use guides every aspect of our design philosophy. At VytronUS, patient safety is always our first priority and improved efficacy is our mission. We look forward to making our products available to doctors and their patients in the near future.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.vytronus.com
  • 658 North Pastoria Ave
    Sunnyvale, CA USA 94085
  • Phone: 408.730.1333

Executives

Name Title Contact Details

Funding

VytronUS raised $49M on 07/29/2016

Similar Companies

Mitchell Laboratories Inc

Mitchell Laboratories Inc is a Pico Rivera, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DiaDexus

Diadexus is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. We pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker`s utility. Our products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014. Our pipeline of advanced cardiac biomarkers includes biomarkers for heart failure, proADM, proET-1 and proANP. Each marker gives distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. Our portfolio of advanced cardiac biomarkers is available to be paired with novel therapeutics in development for indications where cardiovascular risk information would provide valuable insights. This information can be used by pharmaceutical companies in targeting the appropriate patient population and understanding the potential long-term side effects for their therapeutics, potentially avoiding long-term follow up studies.

New Jersey Micro-electronic Testing Inc

New Jersey Micro-electronic Testing Inc is a Clifton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Qlogic

Qlogic is a Evergreen, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Imaging Of Teaneck

Medical Imaging Of Teaneck is a Teaneck, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.